This content is from: Premium
Inside Sarissa’s Healthy Returns
Why the Tiger Cub and Icahn alum is outperforming other health-care funds.
It has been a rough year for many health-care-focused hedge funds, with a number of them either in the red or barely breaking even.Not Sarissa Capital Management’s funds, however.Its main long-short fund, Sarissa Capital, was up 18.1 percent in the first half of the year, while Sarissa Capital Domestic Fund
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.